NCT05607459

Brief Summary

Since neck pain is the fourth highest disabling condition (with an estimated point prevalence of 20%, lifetime prevalence up to 70% and high recurrence rates), dry needling targeting myofascial trigger points in neck muscles has been proposed as an effective treatment for reducing pain and disability in patients with chronic neck pain. A recent meta-analysis reported whether dry needling could be recommended for this population. Low to moderate evidence suggests that dry needling can be effective at the short-term, but its effects on pressure pain sensitivity or cervical range of motion are limited.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 28, 2022

Completed
4 days until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 7, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 28, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
Last Updated

July 1, 2025

Status Verified

June 1, 2025

Enrollment Period

2.4 years

First QC Date

October 28, 2022

Last Update Submit

June 30, 2025

Conditions

Keywords

Dry Needling

Outcome Measures

Primary Outcomes (5)

  • Visual Analogue Scale

    A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)

    Baseline

  • Visual Analogue Scale

    A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)

    One month follow-up

  • Visual Analogue Scale

    A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)

    Three months follow-up

  • Visual Analogue Scale

    A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)

    Six months follow-up

  • Visual Analogue Scale

    A 100mm visual analogue scale will be used. The patient will indicate the level of pain intensity from 0 (no pain) to 10 (the worst pain imaginable)

    Twelve months follow-up

Secondary Outcomes (20)

  • Pittsburg Sleeping Quality Index

    Baseline

  • Pittsburg Sleeping Quality Index

    One month follow-up

  • Pittsburg Sleeping Quality Index

    Three months follow-up

  • Pittsburg Sleeping Quality Index

    Six months follow-up

  • Pittsburg Sleeping Quality Index

    Twelve months follow-up

  • +15 more secondary outcomes

Study Arms (2)

Dry Needling Group

EXPERIMENTAL

This group will receive dry needling, manual therapy (consisting of a manual compression over myofascial trigger points located at the upper trapezius muscle, scalene muscles and cervical multifidus) and therapeutic exercise interventions

Other: Dry NeedlingBehavioral: Therapeutic ExerciseOther: Manual Therapy

Sham Dry Needling Group

ACTIVE COMPARATOR

This group will receive manual therapy (consisting of a manual compression over myofascial trigger points located at the upper trapezius muscle, scalene muscles and cervical multifidus), therapeutic exercise interventions and a previously described sham dry needling intervention.

Behavioral: Therapeutic ExerciseOther: Manual TherapyOther: Sham Dry Needling

Interventions

Dry needling consists of a skilled intervention which uses a thin filiform needle (as those used in acupuncture) to penetrate the skin and stimulate underlying myofascial trigger points (defined as "a hyperirritable spot in skeletal muscle that is associated with a hypersensitive palpable nodule in a taut band which is painful on manual compression and can give rise to characteristic referred pain, referred tenderness, motor dysfunction and autonomic phenomena.") This intervention will be performed targeting the upper trapezius and cervical multifidus muscles

Dry Needling Group

Patients will include a supervised therapeutic exercise program in their daily life, based on strengthening exercises for neck muscles.

Dry Needling GroupSham Dry Needling Group

Patients will receive a manual compression (30 seconds) over myofascial trigger points located at the upper trapezius muscle, scalene muscles and cervical multifidus muscle.

Dry Needling GroupSham Dry Needling Group

For the sham DN intervention, a similar approach will be used, but the skin will be not pierced since the material used will be a telescopic Park's sham device. The guide tube will be pressed against the skin mark and the sham needle will be allowed to drop. The handle will be tapped briskly, but the (blunted) needle tip will not not break the skin.

Sham Dry Needling Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be between 18 and 65 years old
  • To have been experiencing unilateral neck pain for at least 3 months
  • To have a Neck Disability Index (NDI) score \>8
  • To have a Visual Analogue Scale (VAS) score \>3
  • To have at least one active MTrP located in the upper trapezius or cervical multifidus muscles

You may not qualify if:

  • History of whiplash injury
  • Previous cervical surgery
  • Cervical radiculopathy or myelopathy
  • Diagnosis of fibromyalgia
  • Additional analgesic treatments during the study (e.g. physiotherapy or drugs)
  • Psychiatric disorders
  • Any contraindication to the interventions proposed (e.g. fear of needles or anticoagulants)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Juan Antonio Valera-Calero

Alcorcón, Madrid, 28922, Spain

Location

MeSH Terms

Conditions

Neck Pain

Interventions

Dry NeedlingExercise TherapyMusculoskeletal Manipulations

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitationAftercareContinuity of Patient CarePatient Care

Study Officials

  • Juan Antonio Valera Calero, PhD

    Camilo José Cela University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized, parallel, controlled and single-blinded clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice-dean of research

Study Record Dates

First Submitted

October 28, 2022

First Posted

November 7, 2022

Study Start

November 1, 2022

Primary Completion

March 28, 2025

Study Completion

March 30, 2025

Last Updated

July 1, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations